+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bone Grafts and Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • PDF Icon

    Report

  • 350 Pages
  • May 2023
  • Region: Global
  • GlobalData
  • ID: 5821006
The publisher's Medical Devices sector report, 'Bone Grafts and Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Bone Grafts and Substitutes pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Bone Grafts and Substitutes are used in surgical procedures of bones in the human body under two cases either when there is a breakage in the bone or in the case of a void between or in the bones due to number of factors such as age and degenerative diseases.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Bone Grafts and Substitutes under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Bone Grafts and Substitutes and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Bone Grafts and Substitutes under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
2 Introduction
2.1 Bone Grafts and Substitutes Overview
3 Products under Development
3.1 Bone Grafts and Substitutes - Pipeline Products by Stage of Development
3.2 Bone Grafts and Substitutes - Pipeline Products by Segment
3.3 Bone Grafts and Substitutes - Pipeline Products by Territory
3.4 Bone Grafts and Substitutes - Pipeline Products by Regulatory Path
3.5 Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date
3.6 Bone Grafts and Substitutes - Ongoing Clinical Trials
4 Bone Grafts and Substitutes - Pipeline Products under Development by Companies
4.1 Bone Grafts and Substitutes Companies - Pipeline Products by Stage of Development
4.2 Bone Grafts and Substitutes - Pipeline Products by Stage of Development
5 Bone Grafts and Substitutes Companies and Product Overview6 Bone Grafts and Substitutes- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Bone Grafts and Substitutes - Pipeline Products by Stage of Development
  • Bone Grafts and Substitutes - Pipeline Products by Segment
  • Bone Grafts and Substitutes - Pipeline Products by Territory
  • Bone Grafts and Substitutes - Pipeline Products by Regulatory Path
  • Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date
  • Bone Grafts and Substitutes - Ongoing Clinical Trials
  • Bone Grafts and Substitutes Companies - Pipeline Products by Stage of Development
  • Bone Grafts and Substitutes - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Bone Grafts and Substitutes - Pipeline Products by Stage of Development
  • Bone Grafts and Substitutes - Pipeline Products by Segment
  • Bone Grafts and Substitutes - Pipeline Products by Territory
  • Bone Grafts and Substitutes - Pipeline Products by Regulatory Path
  • Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date
  • Bone Grafts and Substitutes - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Acro Biomedical Co Ltd
  • Acuitive Technologies Inc
  • Adocia SAS
  • Aesculap Biologics LLC
  • Agenta Biotechnologies Inc (Inactive)
  • Amend Surgical, Inc.
  • Anika Therapeutics Inc
  • Antibe Therapeutics Inc
  • Aperion Biologics Corp
  • Arthro Kinetics AG
  • Arugula Sciences LLC
  • Aursos, Inc (Inactive)
  • Baxter International Inc
  • BellaSeno GmbH
  • Berkeley Advanced Biomaterials Inc
  • Bio2 Technologies Inc
  • Bioactive Bone Substitutes Plc
  • BioGend Therapeutics Co Ltd
  • Biomatlante SA
  • Bioregeneration Technologies, Inc
  • Biorez Inc
  • Bio-Scaffold International Pte Ltd
  • Bioventus Inc
  • BonAlive Biomaterials Ltd.
  • Bone Biologics Corp
  • Bone Solutions Inc
  • BoneGrafix, Inc.
  • BoneSupport AB
  • Bonus BioGroup Ltd
  • Calcitec, Inc.
  • Carmell Therapeutics Corp
  • Case Western Reserve University
  • Cellumed Co Ltd
  • CeraPedics Inc
  • Citrics Biomedical, LLC (Inactive)
  • Collagen Solutions Ltd
  • Collplant Biotechnologies Ltd
  • Daewoong Pharmaceutical Co Ltd
  • Department of Biomedical Engineering Columbia University
  • Dimension Inx LLC
  • Drexel University
  • DSM Biomedical BV
  • Element Orthopedics Inc (Inactive)
  • Elute Inc
  • ElutInc
  • Ember Therapeutics Inc
  • EpiBone Inc
  • Eskisehir Osmangazi University
  • EternoGen Aesthetics LLC
  • Exactech Inc
  • Ferring Pharmaceuticals AS
  • Fuse Medical Inc
  • Gene Biotherapeutics Inc
  • Graftoss Limited
  • Graftys SA
  • Hangzhou Huamai Medical Equipment Co Ltd
  • Hospital for Special Surgery
  • Indian Institute of Technology Bombay
  • Induce Biologics Inc.
  • Industrie Biomediche Insubri SA
  • Innovoss Inc. (Inactive)
  • IRCCS San Raffaele Hospital
  • Isto Biologics
  • Johns Hopkins University
  • kasios sas
  • King's College London
  • Kuros Biosciences AG
  • Lattice Biologics Ltd
  • Locate Bio Ltd
  • Maxigen Biotech Inc
  • Medisse BV (Inactive)
  • Medtronic Plc
  • MEGA Bio Pharma
  • Miromatrix Medical Inc
  • N2 Biomedical
  • NanoFUSE Biologics LLC
  • National Center of Innovation for Biomaterials in Orthopaedic Research
  • National University of Science and Technology MiSiS
  • Nutech Medical Inc
  • NuVasive Inc
  • Orthocell Ltd
  • OrthoMedex LLC
  • Orthosera GmbH
  • OssiFi Inc
  • OsteoNovus, LLC
  • Osteopore International Pte Ltd
  • Particle3D
  • PolyPid Ltd
  • Polytechnic University of Catalonia
  • Promimic AB
  • ReCaPP
  • RepRegen Ltd. (Inactive)
  • Revivicor Inc
  • Richard L. Roudebush VAMC
  • ROKIT Healthcare Inc
  • Sanara MedTech Inc
  • Scil Technology GmbH
  • SDIP Innovations Pty Ltd
  • SeaSpine, Inc.
  • Serigen Mediproducts Pvt Ltd
  • SIRAKOSS Ltd
  • Smith & Nephew Inc
  • Sofregen Medical Inc
  • Soteira Inc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • STEL Technologies LLC
  • SurgaColl Technologies Ltd
  • Surgalign Holdings Inc
  • SurGenTec LLC
  • T&R Biofab Co Ltd
  • TBF Genie Tissulaire
  • The Chinese University of Hong Kong
  • Theragnostic Technologies Inc
  • Tissue Regeneration Systems, Inc.
  • Trinity College Dublin
  • University of California San Diego
  • University of Edinburgh
  • University of Malaya
  • University of Maryland
  • University of Massachusetts Amherst
  • University of Memphis
  • University of Missouri
  • University of Pecs
  • University of South Florida
  • UNSW Medicine
  • Vanderbilt University
  • Vivex Biologics Inc
  • Wayne State University
  • Wright Medical Group NV (Inactive)
  • Xtant Medical Holdings Inc